Results 151 to 160 of about 8,373 (339)

Effects of passive smoking on heart rate variability, heart rate and blood pressure: an observational study [PDF]

, 2017
Background Exposure to environmental tobacco smoke (ETS) has been shown to increase the risk for cardiovascular diseases and death, and autonomic dysfunction (specifically, reduced heart rate variability (HRV)) is a predictor of increased cardiac risk ...
Ackermann-Liebrich, Ursula, Barthélémy, Jean-Claude, Brändli, Otto, Felber Dietrich, Denise, Gaspoz, Jean-Michel, Gold, Diane R., Leuenberger, Philippe, Roche, Frédéric, Schindler, Christian, Schwartz, Joel, Tschopp, Jean-Marie, von Eckardstein, Arnold   +11 more
core  

Beta‐adrenoceptor blocking drugs: the relevance of intrinsic sympathomimetic activity. [PDF]

, 1982
Louis Wj, John J. McNeil
openalex   +1 more source

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial

Neurourology and Urodynamics, EarlyView.
ABSTRACT Purpose Vibegron was associated with improvements in efficacy versus placebo and was well tolerated in men with overactive bladder (OAB) on pharmacotherapy for benign prostatic hyperplasia (BPH) in the COURAGE trial (NCT03902080). Additional safety, bladder function, and urodynamics data are provided.
Eric S. Rovner, Janet Owens‐Grillo, Elizabeth Thomas, Sender Herschorn, Kenneth M. Peters, David Staskin, Salim Mujais   +6 more
wiley   +1 more source

FURTHER STUDIES ON THE SYMPATHOMIMETIC ACTION OF TETANUS TOXIN

, 1971
R K Sanyal, Meena DAVE
openalex   +1 more source

GDF15: Anxiety Signalling From the Adipose Tissue

iNew Medicine, EarlyView.
Song‐Yang Zhang
wiley   +1 more source

Addition of Phentermine‐Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double‐Blind Randomized Clinical Trial

Obesity, EarlyView.
ABSTRACT Objective This study compared the effects of phentermine‐topiramate‐ER (mid‐dose 7.5/46 mg) versus placebo on weight loss and cardiovascular disease (CVD) risk outcomes when used as an adjunct to a digitally enhanced lifestyle intervention (DELI).
Alejandro Campos, Wissam Ghusn, Lizeth Cifuentes, Daniel Sacoto, Sima Fansa, Diego Anazco, Maria L. Ricardo‐Silgado, Anas Hashem, Megan Schaefer, William S. Harmsen, Heather J. Gunn, Craig Peterson, Deborah Larsen, Santosh T. Varghese, Maria D. Hurtado, Andres Acosta   +15 more
wiley   +1 more source

Effect of a .BETA.-blocker celiprolol on hemodynamics during exercise loading and the responses caused by sympathomimetic drugs in essential hypertensives.

, 1990
Toshihiro Saito, Fujio Deguchi, Masako Kishi, Toshiaki NAKATUKA, Kazutoshi Yamamoto, Jiro Iwata, Yosiaki Inagaki   +6 more
openalex   +2 more sources

Kaposiform hemangioendothelioma: Diagnosis and treatment

Pediatric Investigation, EarlyView.
Vascular endothelial growth factor‐C (VEGF‐C)/vascular endothelial growth factor receptor‐3 (VEGFR‐3) and angiopoietin‐2 (Ang‐2)/tyrosine kinase with immunoglobulin‐like and EGF‐like domain 2 (TIE2) signaling pathways play an important role in lymphangiogenesis.
Yi Tian, Yuanyuan Tian, Li Wei, Zigang Xu, Li Li, Lin Ma   +5 more
wiley   +1 more source

The Effect of Posture on Hypertension Induced by Sympathomimetic Amines in Man [PDF]

, 1952
A Littman, RALPH M. GUNNAR, Morton I. Grossman, Raúl Casas   +3 more
openalex   +1 more source

The Use of Non‐Selective Beta‐Blockers in Cirrhotic Portal Hypertension

Portal Hypertension &Cirrhosis, EarlyView.
Non‐selective beta‐blockers (NSBBs) reduce portal pressure and play a key role in preventing variceal bleeding, managing ascites, and preventing hepatocellular carcinoma (HCC) in cirrhotic patients. Their clinical application requires individualized strategies and further optimization of indications. ABSTRACT Liver cirrhosis is the end stage of various
Tong Bu, Tianyuan Yang, Qi Wang
wiley   +1 more source